Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 102

    Biocon Q1 profit rises 72 percent to Rs 206 crore

    Biocon Q1 profit rises 72 percent to Rs 206 crore

    Medical Dialogues Bureau28 July 2019 10:00 AM IST
    "Robust performance by our biologics and small molecules business segments fuelled the 25 per cent growth in Q1 FY20 revenue to Rs 1,490 crore,"...
    Bayer high-precision cancer drug Vitrakvi in frame to receive first EU nod

    Bayer high-precision cancer drug Vitrakvi in frame to receive first EU nod

    Medical Dialogues Bureau28 July 2019 9:45 AM IST
    Bayer earlier this year took full control of Vitrakvi in a deal with Eli Lilly's Loxo Oncology, and the European thumbs-up follows U.S. regulatory...
    Hamdard Labs launches Wellness Centres in Ghaziabad, Meerut

    Hamdard Labs launches Wellness Centres in Ghaziabad, Meerut

    Medical Dialogues Bureau28 July 2019 9:30 AM IST
    The objective is to spread the natural healing touch of Unani and reach out to people wanting natural, herbal treatment for lifestyle diseases, and a...
    Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel

    Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel

    Medical Dialogues Bureau28 July 2019 9:17 AM IST
    Sales of Eliquis, which Bristol-Myers shares with Pfizer Inc (PFE.N), rose 24% to $2.04 billion, while Orencia sales rose 9% to $778 million, both...
    GW Pharma cannabis drug Epidiolex wins European panel nod

    GW Pharma cannabis drug Epidiolex wins European panel nod

    Medical Dialogues Bureau28 July 2019 9:15 AM IST
    Epidiolex is made up of cannabidiol (CBD), one of the hundreds of molecules found in the marijuana plant, and contains less than 0.1 per cent of...
    Important to regulate use of antibiotics in animals, humans: Harsh Vardhan

    Important to regulate use of antibiotics in animals, humans: Harsh Vardhan

    Medical Dialogues Bureau27 July 2019 10:00 AM IST
    "Use of antibiotics in chickens, in particular, is expected to triple in India by 2030 and therefore it is important to regulate the use of...
    Indoco Remedies receives EIR from USFDA for sterile, solid dosages facility in Goa

    Indoco Remedies receives EIR from USFDA for sterile, solid dosages facility in Goa

    Medical Dialogues Bureau27 July 2019 9:45 AM IST
    The inspection was held from May 27-June 4, 2019 and the company received four Form 483 observations, Indoco Remedies said in a filing to BSE.NEW...
    Do not BAN, regulate sale, use of e-cigarettes, other ENDS devices: Trade representatives of ENDS

    Do not BAN, regulate sale, use of e-cigarettes, other ENDS devices: Trade representatives of ENDS

    Medical Dialogues Bureau27 July 2019 9:30 AM IST
    The appeal comes days after the Delhi High Court directed the Kejriwal government to urgently look into the matter of regulating the sale and...
    Medtronic unveils VenaSeal Closure System in India to treat patients with CVD

    Medtronic unveils VenaSeal Closure System in India to treat patients with CVD

    Medical Dialogues Bureau27 July 2019 9:15 AM IST
    Mumbai: India Medtronic Private Limited, wholly-owned subsidiary of Medtronic plc, announced the launch of the VenaSeal Closure System, which is a...
    Biocon appoints Mayank Verma as Company Secretary, Compliance Officer

    Biocon appoints Mayank Verma as Company Secretary, Compliance Officer

    Farhat Nasim27 July 2019 9:00 AM IST
    Prior to joining the Biocon Group, Mayank Verma has worked with ING Vysya Bank Limited from 2007 to 2012.New Delhi: Biotechnology major, Biocon has...
    Patent Infringement: AstraZeneca moves US court against Dr Reddys on generic version of blockbuster Brilinta

    Patent Infringement: AstraZeneca moves US court against Dr Reddy's on generic version of blockbuster Brilinta

    Medical Dialogues Bureau26 July 2019 12:11 PM IST
    In a petition filed in the District Court of New Jersey on July 23, AstraZeneca alleged Dr Reddy's Lab's proposed generic Brilinta will infringe the...
    Cipla arm acquires anti-infective Zemdri from Achaogen to treat cUTI

    Cipla arm acquires anti-infective Zemdri from Achaogen to treat cUTI

    Medical Dialogues Bureau26 July 2019 9:45 AM IST
    Cipla USA has acquired worldwide rights of Zemdri, excluding Greater China, with its allied assets and limited liabilities, Cipla said in a late-night...
    PrevNext

    Popular Stories

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    No discussion on alleged bribes given by pharma firms to doctors at PM Modis meet, claims IPA

    No discussion on alleged bribes given by pharma firms to doctors at PM Modi's meet, claims IPA

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    FICCI raises concern on delay by govt in notifying E-pharmacy rules

    FICCI raises concern on delay by govt in notifying E-pharmacy rules

    OncoStem Diagnostics named

    OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and...

    Protect Your Loved Ones with a Term Plan that’s Smart

    Protect Your Loved Ones with a Term Plan that’s Smart

    Strides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MD

    Strides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MD

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok